In summary, we present a novel small-moleculeSTAT3 inhibitor YY002,which simultaneously inhibited STAT3 Tyr705 and Ser727 phosphorylation.YY002 potently inhibited pancreatic tumor growth and metastasis, andalso exhibited favorable pharmacokinetics and an acceptable safetyprofile. The gene discussed is STAT3; the disease is pancreatic neoplasm.